Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Carlos H. Ramirez-Ronda"'
Autor:
Keith Bragman, Robert P. Myers, Stefano Vella, Jean-François Delfraissy, Hans-Jürgen Stellbrink, Carlos H. Ramirez-Ronda, Nathan Clumeck, M. John Gill, David A. Hawkins, David A. Cooper, Miklos Salgo
Publikováno v:
Clinical Drug Investigation. 20:295-307
Background: PISCES (SV14604) was the largest study of antiretroviral therapy to assess clinical end-points. The study data provides a repository of important information, much of which remains relevant today. This paper reviews the results of the PIS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8ba10d8c6013e5fcd409a0ed6d0720f
https://doi.org/10.2165/00044011-200020050-00001
https://doi.org/10.2165/00044011-200020050-00001
Publikováno v:
The American Journal of Medicine. 100:90S-95S
The purpose of this study was to compare in a randomized, open-label clinical study, the efficacy and safety of cefepime (1 g every 12 hours) with that of ceftazidime (1 g every 8 hours) in patients with serious skin and skinstructure infections. Of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c492b1bfeb7cc297f05993b55cd9e0a
https://doi.org/10.1016/s0002-9343(96)00111-8
https://doi.org/10.1016/s0002-9343(96)00111-8
Autor:
P. Richard Harrigan, Ray McKinnis, Lewis Lefkowitz, Jan W. Mulder, Helen C. Steel, Mark D. Moore, Brendan Larder, Ian Kinghorn, James Lavelle, Robert T. Schooley, David A. Cooper, Marty St. Clair, Joep M. A. Lange, Kevin N. Pennington, Carlos H. Ramirez-Ronda, James F. Rooney
Publikováno v:
Journal of Infectious Diseases. 173:1354-1366
A randomized controlled study was done to determine whether initial combination therapy with zidovudine and zalcitabine or zidovudine and didanosine would delay the emergence of zidovudine-resistant virus. Human immunodeficiency virus (HIV)-1-infecte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::314128c305272243d8ecf91144f427de
https://doi.org/10.1093/infdis/173.6.1354
https://doi.org/10.1093/infdis/173.6.1354
Autor:
Eskild A. Petersen, Henry S. Sacks, Dolores M. Peterson, Robert E. Anderson, Hardy Wd, Carlos H. Ramirez-Ronda, Lisa M. Dunkle, Schwartz R, Anne Cross, Follansbee S
Publikováno v:
Journal of Infectious Diseases. 171:S131-S139
In a multicenter, randomized, open-label, dose-ranging study to determine the relative effects of three dose levels of stavudine on CD4 lymphocyte count, weight gain, and hematologic variables in patients infected with human immunodeficiency virus (H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3bc01061b48e6daf38ad011199b72fd
https://doi.org/10.1093/infdis/171.supplement_2.s131
https://doi.org/10.1093/infdis/171.supplement_2.s131
Publikováno v:
Infectious Disease Clinics of North America. 8:107-128
SUMMARY Dengue is an important insect-bome viral disease, transmitted in the Western hemisphere by the A. aegypti mosquito. It is endemic in the Caribbean with sporadic outbreaks in different regions. Cases in the United States are mostly imported ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18c85cf0cb9f951ba9cc53d3f1be0975
https://doi.org/10.1016/s0891-5520(20)30576-6
https://doi.org/10.1016/s0891-5520(20)30576-6
Autor:
Luis A, Duharte Vidaurre, Carlos H, Ramirez-Ronda, Glenda, Gonzalez Claudio, Sonia, Vicenty Rivera, Eric, Aviles Rivera, Luis, Rodriguez Ospina, Beatriz, Triana, Eva, Trinidad Espada, Merida, Colón Cabán
Publikováno v:
Boletin de la Asociacion Medica de Puerto Rico. 97(3 Pt 2)
Prosthetic valve infective endocarditis represents a defined pathological entity which follows an epidemiological and nosological pattern in accordance to an arbitrary classification. Chronologically it is divided into the entities of early and late
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7776cbc87fe240d7a015e4eb49b667e4
https://pubmed.ncbi.nlm.nih.gov/16320907
https://pubmed.ncbi.nlm.nih.gov/16320907
Autor:
Carlos H. Ramirez-Ronda, Bach-Yen Nguyen, Jorge Benetucci, Chodakewitz Jeffrey A, Pedro Cahn, Rogiero De Jesus Pedro, Melanie A. Thompson, L. Miguel Noriega, Patricia Uribe, Charlotte M. Harvey, Judith S. Currier, Mi Ok Chung, A. Clinton White, Eduardo Arathoon, Devan V. Mehrotra, David P. Paar, David Salomão Lewi, David W. Haas, David Everson Uip, Joel E. Gallant, Ann C. Collier
Publikováno v:
AIDS (London, England). 14(13)
Objectives: To compare the efficacy and safety of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine. Design: Two multicenter, open-label, randomized 24-week studies. Methods: Adults HIV-1 infection, HIV-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f86fe1a3701bc2cb13503eb8bb54d776
https://pubmed.ncbi.nlm.nih.gov/10997402
https://pubmed.ncbi.nlm.nih.gov/10997402
Autor:
Carlos H. Ramirez-Ronda, James F. Rooney, Ian Frank, Ray McKinnis, Eskild A. Petersen, George Perez, Stephen B. Greenberg, David H. Shepp, Gregory J. Mertz, Harold A. Kessler, Renslow Sherer, David J. Gocke, Mark D. Moore, Richard B. Pollard, Robert L. Murphy, Lawrence Dall
Publikováno v:
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 15(4)
Zidovudine is approved for administration in doses given every 4 hours. Less frequent dosing has been used in many clinical trials, but the toxicity and efficacy of such regimens have not been formally compared with the approved regimen. In this mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::084e339bc88fd7dc3670563766659b7d
https://pubmed.ncbi.nlm.nih.gov/9292587
https://pubmed.ncbi.nlm.nih.gov/9292587
Autor:
Melanie A. Thompson, Lawrence R. Crane, Scot C. Remick, Ian Frank, Laurie Smaldone, Dolores M. Peterson, Carlos H. Ramirez-Ronda, Ronald Gugliotti, Thomas F. Patterson, Anne Cross, Andrew T. Pavia, Peter Ingraham, Allison Berry, Michael J. Brown, G. E. Morey, Richard B. Pollard, Donna E. Sweet, Adan Rios, Eskild A. Peterson, Rodger D. MacArthur, Stephen L. Green, Constance T. Pachucki, Spotswood L. Spruance, Jerry Brand, Andrew H. Schindzielorz, Bernstein Barry M, Lisa M. Dunkle
Publikováno v:
Annals of Internal Medicine. 120:360
OBJECTIVE To determine the benefits of switching to didanosine compared with continuing zidovudine among patients infected with human immunodeficiency virus (HIV) who have previously used zidovudine and have signs of clinical deterioration. DESIGN Ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::590d9912d62480fe83ce864379ecc9c8
https://doi.org/10.7326/0003-4819-120-5-199403010-00002
https://doi.org/10.7326/0003-4819-120-5-199403010-00002
Publikováno v:
Journal of Antimicrobial Chemotherapy. 10:209-213
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::554b797d1d9f6193e92b18383f4ad0ce
https://doi.org/10.1093/jac/10.suppl_c.209
https://doi.org/10.1093/jac/10.suppl_c.209